Inari Financial Statements From 2010 to 2024

NARI Stock  USD 49.48  0.18  0.36%   
Inari Medical financial statements provide useful quarterly and yearly information to potential Inari Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Inari Medical financial statements helps investors assess Inari Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Inari Medical's valuation are summarized below:
Gross Profit
339 M
Profit Margin
(0.14)
Market Capitalization
2.9 B
Enterprise Value Revenue
4.9234
Revenue
574.5 M
We have found one hundred twenty available fundamental trends for Inari Medical, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Inari Medical regular fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 2.4 B. Enterprise Value is estimated to decrease to about 2.4 B

Inari Medical Total Revenue

247.81 Million

Check Inari Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inari Medical's main balance sheet or income statement drivers, such as Net Interest Income of 16.2 M, Interest Income of 16.4 M or Depreciation And Amortization of 11.3 M, as well as many indicators such as Price To Sales Ratio of 7.09, Dividend Yield of 0.0 or PTB Ratio of 8.32. Inari financial statements analysis is a perfect complement when working with Inari Medical Valuation or Volatility modules.
  
Check out the analysis of Inari Medical Correlation against competitors.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

Inari Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets707.9 M674.2 M179.9 M
Slightly volatile
Short and Long Term Debt Total27 M32 M17.2 M
Slightly volatile
Other Current Liabilities65.5 M62.4 M15.9 M
Slightly volatile
Total Current Liabilities80.2 M76.3 M19.8 M
Slightly volatile
Property Plant And Equipment Net39.4 M69.3 M17.4 M
Slightly volatile
Accounts Payable5.7 M10.6 M2.8 M
Slightly volatile
Cash64.4 M38.6 M39.4 M
Slightly volatile
Non Current Assets Total460.6 M438.7 M71.3 M
Slightly volatile
Non Currrent Assets Other2.7 M2.6 M609.4 K
Slightly volatile
Other Assets949.3 K677.4 K405.2 K
Slightly volatile
Long Term Debt16.1 M22.4 M13.7 M
Slightly volatile
Cash And Short Term Investments151.7 M115.5 M76.9 M
Slightly volatile
Net Receivables39 M70.1 M18 M
Slightly volatile
Common Stock Total Equity30.8 K57.5 K20.1 K
Slightly volatile
Common Stock Shares Outstanding56.8 M56.8 M48.4 M
Slightly volatile
Long Term Debt Total16.1 M22.4 M13.7 M
Slightly volatile
Liabilities And Stockholders Equity707.9 M674.2 M179.9 M
Slightly volatile
Non Current Liabilities Total139.6 M133 M66 M
Pretty Stable
Capital Surpluse310.5 M295.7 M90.9 M
Slightly volatile
Inventory45 M42.9 M11.1 M
Slightly volatile
Other Current AssetsM7.1 MM
Slightly volatile
Other Stockholder Equity266.9 M504.5 M115.8 M
Slightly volatile
Total Liabilities219.8 M209.3 M85.6 M
Slightly volatile
Property Plant And Equipment Gross41.9 M83 M18.5 M
Slightly volatile
Total Current Assets215.4 M235.6 M106.5 M
Slightly volatile
Capital Stock41.1 K58 K21 K
Slightly volatile
Net Working Capital178.7 M159.2 M89.6 M
Slightly volatile
Common Stock41.1 K58 K21 K
Slightly volatile
Property Plant Equipment87.4 M83.2 M18.6 M
Slightly volatile
Deferred Long Term Liabilities45.3 K47.7 KM
Slightly volatile
Short Term Investments131 M76.9 M73.8 M
Slightly volatile
Other Liabilities1.1 M1.3 M1.4 M
Slightly volatile
Non Current Liabilities Other80.2 M76.4 M16 M
Slightly volatile
Short Term Debt2.8 M3.4 M1.9 M
Slightly volatile
Intangible Assets120.7 M135.8 M147.9 M
Slightly volatile

Inari Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income16.4 M15.6 M2.4 M
Slightly volatile
Depreciation And Amortization11.3 M10.7 M2.6 M
Slightly volatile
Interest Expense186.2 K196 K734 K
Slightly volatile
Selling General Administrative177.6 M349.5 M82.1 M
Slightly volatile
Selling And Marketing Expenses1.3 M1.2 M279 K
Slightly volatile
Total Revenue247.8 M493.6 M110.3 M
Slightly volatile
Gross Profit220.6 M434.6 M97.9 M
Slightly volatile
Other Operating Expenses533 M507.7 M135.6 M
Slightly volatile
Research Development44.4 M87.5 M21.2 M
Slightly volatile
Cost Of Revenue62 M59.1 M14.7 M
Slightly volatile
Total Operating Expenses224.5 M448.6 M104.4 M
Slightly volatile
Reconciled Depreciation11.3 M10.7 M2.5 M
Slightly volatile

Inari Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation42.4 M40.3 M9.5 M
Slightly volatile
Begin Period Cash Flow58.7 M60.2 M28.9 M
Slightly volatile
Depreciation11.3 M10.7 M2.5 M
Slightly volatile
Capital Expenditures7.2 M6.2 M3.5 M
Slightly volatile
Change To Operating Activities4.3 MM2.5 M
Slightly volatile
Total Cash From Financing Activities1.1 M1.2 M38.6 M
Pretty Stable
End Period Cash Flow64.7 M39.2 M39.5 M
Slightly volatile
Change To Netincome35.6 M33.9 M9.2 M
Slightly volatile
Change To Liabilities1.6 M1.3 M884.3 K
Slightly volatile
Dividends Paid20 K22.5 K24.5 K
Slightly volatile
Cash Flows Other Operating5.5 M9.6 M3.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.097.4662175
Slightly volatile
Days Sales Outstanding80.0351.847297.988
Slightly volatile
Stock Based Compensation To Revenue0.04260.08170.0435
Slightly volatile
Capex To Depreciation0.550.57712.5804
Slightly volatile
EV To Sales7.087.4529173
Slightly volatile
Inventory Turnover1.041.37691.2157
Slightly volatile
Days Of Inventory On Hand310265300
Slightly volatile
Payables Turnover3.145.58462.739
Slightly volatile
Sales General And Administrative To Revenue0.940.70791.2374
Slightly volatile
Average Inventory5.8 M6.5 M7.1 M
Slightly volatile
Research And Ddevelopement To Revenue0.260.17730.4231
Slightly volatile
Capex To Revenue0.01190.01260.0795
Slightly volatile
Cash Per Share2.382.03371.6076
Slightly volatile
Days Payables Outstanding12365.3587161
Slightly volatile
Intangibles To Total Assets0.430.490.5308
Slightly volatile
Current Ratio2.933.08579.8958
Slightly volatile
Receivables Turnover4.367.03994.104
Slightly volatile
Graham Number3.682.30433.2106
Slightly volatile
Capex Per Share0.110.10920.0712
Slightly volatile
Revenue Per Share9.138.69522.4954
Slightly volatile
Interest Debt Per Share0.03160.03330.1815
Slightly volatile
Debt To Assets0.00240.00250.2494
Slightly volatile
Operating Cycle390317398
Slightly volatile
Days Of Payables Outstanding12365.3587161
Slightly volatile
Quick Ratio2.42.52389.3623
Slightly volatile
Cash Ratio0.480.50567.1672
Slightly volatile
Cash Conversion Cycle195252231
Pretty Stable
Days Of Inventory Outstanding310265300
Slightly volatile
Days Of Sales Outstanding80.0351.847297.988
Slightly volatile
Fixed Asset Turnover10.697.11948.5604
Pretty Stable
Debt Ratio0.00240.00250.2494
Slightly volatile
Price Sales Ratio7.097.4662175
Slightly volatile
Asset Turnover0.590.73210.4704
Slightly volatile
Gross Profit Margin0.70.88030.8318
Pretty Stable

Inari Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B3.7 B2.4 B
Slightly volatile
Enterprise Value2.4 B3.7 B2.4 B
Slightly volatile

Inari Fundamental Market Drivers

Forward Price Earnings227.2727
Cash And Short Term Investments115.5 M

Inari Upcoming Events

26th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Inari Medical Financial Statements

Investors use fundamental indicators, such as Inari Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Inari Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Revenue493.6 M247.8 M
Cost Of Revenue59.1 M62 M
Stock Based Compensation To Revenue 0.08  0.04 
Sales General And Administrative To Revenue 0.71  0.94 
Research And Ddevelopement To Revenue 0.18  0.26 
Capex To Revenue 0.01  0.01 
Revenue Per Share 8.70  9.13 
Ebit Per Revenue(0.03)(0.03)

Currently Active Assets on Macroaxis

When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:
Check out the analysis of Inari Medical Correlation against competitors.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(1.35)
Revenue Per Share
9.901
Quarterly Revenue Growth
0.214
Return On Assets
(0.03)
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.